Meheus A, Ballard R, Dlamini M, Ursi J P, Van Dyck E, Piot P
Int J Epidemiol. 1980 Sep;9(3):239-45. doi: 10.1093/ije/9.3.239.
The annual incidence of urethritis can be estimated to be at lest 3750 per 100,000 population in Swaziland. In a study of 109 males with symptomatic urethritis 80% had gonorrhoea, 6% non-gonococcal urethritis (ngu) and 14% were classified as having no 'objective' urethritis (less than 5 polymorphonuclear leucocytes per highpower field in the urethral smear). The relative frequency of gonorrhoea was 80 to 95% and of non-gonococcal urethritis 5 to 20 according to which criteria are used for patient selection and/or diagnosis of ngu. Chlamydia trachomatis was cultured in 3.4% of the cases with urethritis, comprising one positive culture in 70 patients with gonorrhoea, one in 5 with ngu, and one in 12 with no 'objective' urethritis. Seventy-one percent of patients, with a comparable percentage in each diagnostic group, had chlamydial antibodies when tested by the micro immunofluorescence test to pooled chlamydial antigens. Interpretation of the chlamydial serologic results indicates that lymphogranuloma venereum is probably endemic in the country, and that oculogenital chlamydial infections are not a problem; this corresponds with the low isolation rate of Chlamydia trachomatis in the urethritis cases. The study shows that the epidemiology and causes of urethritis are clearly of a different pattern to that seen in industrialised countries. This type of study is a sound basis for a simplified but effective urethritis control programme which can be implemented in the para-urban and rural health centres in developing countries.
据估计,斯威士兰尿道炎的年发病率至少为每10万人中有3750例。在一项针对109名有症状尿道炎男性的研究中,80%患有淋病,6%患有非淋菌性尿道炎(NGU),14%被归类为无“客观”尿道炎(尿道涂片每高倍视野多形核白细胞少于5个)。根据用于患者选择和/或NGU诊断的标准,淋病的相对发病率为80%至95%,非淋菌性尿道炎为5%至20%。沙眼衣原体在3.4%的尿道炎病例中培养阳性,其中70例淋病患者中有1例培养阳性,5例NGU患者中有1例,12例无“客观”尿道炎患者中有1例。当通过微量免疫荧光试验检测衣原体混合抗原时,71%的患者(每个诊断组的比例相当)有衣原体抗体。对衣原体血清学结果的解释表明,性病性淋巴肉芽肿在该国可能为地方病,而眼生殖器衣原体感染不是问题;这与尿道炎病例中沙眼衣原体的低分离率相符。该研究表明,尿道炎的流行病学和病因与工业化国家明显不同。这类研究是制定简化但有效的尿道炎控制方案的坚实基础,该方案可在发展中国家的城郊和农村卫生中心实施。